Leading international treaters to speak at Congress

The World Federation of Hemophilia (WFH) 2020 World Congress will feature many leading international bleeding disorder treaters. These key opinions leaders will be at Congress to discuss the current—and future—treatments what will help improve the quality of life of people in the global bleeding disorders community.

Here are brief profiles on several speakers who will be taking part in the WFH 2020 World Congress in Kuala Lumpur, Malaysia, from June 14 to 17, 2020.

Name: Robert Klamroth, MD

Country: Germany 

Positions: Head of the Department of Internal Medicine Angiology and Coagulation Disorders and Director of the Comprehensive Care Hemophilia Treatment Centre and the Hemostasis and Thrombosis Unit at the Vivantes Hospital in Friedrichshain, Berlin, Germany.

WFH 2020 Congress speaker topic: Redefining prophylaxis in the modern era.


Robert Klamroth holds specialist training degrees in internal medicine, angiology, and hemostaseology. He is a member of national and international societies in the field of angiology, thrombosis and hemostasis, and serves as speaker of the hemophilia commission of the German Society of Thrombosis and Haemostasis. He has authored or co-authored peer-reviewed publications, review articles and book chapters.

Name: Sarah H. O’Brien, MD

Country: U.S.A

Positions: Associate Professor, Pediatric Hematology/Oncology and Director of Experimental Therapeutics, Section of Hematology/Oncology/Bone Marrow Transplantation (BMT), Nationwide Children’s Hospital, Columbus, U.S.A

WFH 2020 Congress speaker topic: Screening, practical aspects of identification


Sarah H. O’Brien’s clinical and research interests include pediatric thrombosis and thromboprophylaxis, the evaluation and diagnosis of mild bleeding disorders, and the intersections between hematology and women’s health. She also leads a multidisciplinary hematology and adolescent gynecology clinic at Nationwide Children’s. As a health services researcher, O’Brien has a particular interest in the use of large administrative databases, decision analysis and cost effectiveness analysis to further care. She attended the University of Pittsburgh School of Medicine and received her residency and fellowship training from the Children’s Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC). O’Brien has been voted as a “Best Doctor in America”.

Name: Valder R. Arruda, MD

Country: U.S.A

Positions: Associate Professor of Pediatrics at the University of Pennsylvania School of Medicine, U.S.A.

WFH 2020 Congress speaker topic: Novel approaches to eradicating inhibitors, CAR-B therapy for inhibitors


Valder R. Arruda’s laboratory focuses on the development of gene-based strategies for the treatment of bleeding and thrombotic diseases. Arruda and his colleagues have carried out early-phase clinical studies on adeno-associated viral (AAV) vectors for the treatment of severe hemophilia B (factor IX deficiency). Arruda’s current projects are focused on translational research studies on the efficacy and safety of intravascular delivery of AAV vectors to the skeletal muscle or the liver of dogs and mice with severe hemophilia. He is also working to identify biological factors that modulate AAV vectors transduction and the risk of inadvertent germline transmission in animal models.

Name: Pål Andre Holme, MD

Country: Norway

Positions: Professor of Hematology at the Oslo University Hospital, Rikshospitalet, Norway

WFH 2020 Congress speaker topic: Anti-thrombotic drug management


Pål Andre Holme’s scientific interests are focused on the clinical and basic aspects of normal and disturbed hemostasis. The clinical aspect of his research is concerned with the diagnosis and treatment of disturbances of the thrombohemorrhagic balance. The basic part of his research concerns platelet metabolic and morphologic changes caused by activation by physiological agonists, such as microparticle formation, secretion of chemokines/interleukins, interaction with endothelium and monocytes, initiation and support of coagulation factor activation, and intraplatelet protein synthesis.

In the coming months we will be releasing more information about the WFH 2020 World Congress program. We hope you continue to visit Hemophilia World Online to find out more.

To read about some speakers who will be part of the Congress medical program, please click here.

WFH 2020 World Congress in Kuala Lumpur

Find out more!

To find out more about the WFH 2020 World Congress in Kuala Lumpur please click here.
To register, click here.
To submit your abstract, please click here.